Sanofi Drug Patent Portfolio
Sanofi owns 2 orange book drugs protected by 10 US patents Given below is the list of Sanofi's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7985418 | Aliphatic amine polymer salts for tableting | 27 Oct, 2025 | Active |
| US7148211 | Formulation for lipophilic agents | 14 Sep, 2023 | Expired |
| US6903083 | Stabilized hydroxyvitamin D | 18 Jul, 2021 | Expired |
| US5667775 | Phosphate-binding polymers for oral administration | 16 Sep, 2014 | Expired |
| US5602116 | Method for treating and preventing secondary hyperparathyroidism | 11 Feb, 2014 | Expired |
| US5496545 | Phosphate-binding polymers for oral administration | 11 Aug, 2013 | Expired |
| US6509013 | Method of making phosphate-binding polymers for oral administration | 11 Aug, 2013 | Expired |
| US6858203 | Method of making phosphate-binding polymers for oral administration | 11 Aug, 2013 | Expired |
| US7014846 | Phosphate-binding polymers for oral administration | 11 Aug, 2013 | Expired |
| US7459151 | Phosphate-binding polymers for oral administration | 11 Aug, 2013 | Expired |
Latest Legal Activities on Sanofi's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Sanofi.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Jan, 2023 | US9095509 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 11 Jan, 2023 | US7985418 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 21 May, 2020 | US7459151 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 24 Jan, 2019 | US9095509 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 Jan, 2019 | US7985418 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 31 May, 2018 | US7148211 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 04 Aug, 2015 | US9095509 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 04 Aug, 2015 | US9095509 |
|
Issue Notification Mailed
Critical
| 15 Jul, 2015 | US9095509 |
|
Application Is Considered Ready for Issue
Critical
| 07 Jul, 2015 | US9095509 |
| Dispatch to FDC | 07 Jul, 2015 | US9095509 |
| Mailing Corrected Notice of Allowability | 06 Jul, 2015 | US9095509 |
| Printer Rush- No mailing | 06 Jul, 2015 | US9095509 |
| Corrected Notice of Allowability | 02 Jul, 2015 | US9095509 |
|
Issue Fee Payment Verified
Critical
| 25 Jun, 2015 | US9095509 |
Sanofi's Family Patents
Sanofi Drug List
Given below is the complete list of Sanofi's drugs and the patents protecting them.
1. Hectorol
Hectorol is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7148211 | Formulation for lipophilic agents |
14 Sep, 2023
(1 year, 9 months ago)
| Expired |
| US6903083 | Stabilized hydroxyvitamin D |
18 Jul, 2021
(3 years ago)
| Expired |
| US5602116 | Method for treating and preventing secondary hyperparathyroidism |
11 Feb, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hectorol's drug page
2. Renvela
Renvela is protected by 7 patents, out of which 6 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7985418 | Aliphatic amine polymer salts for tableting |
27 Oct, 2025
(3 months from now)
| Active |
| US5667775 | Phosphate-binding polymers for oral administration |
16 Sep, 2014
(10 years ago)
| Expired |
| US5496545 | Phosphate-binding polymers for oral administration |
11 Aug, 2013
(11 years ago)
| Expired |
| US6509013 | Method of making phosphate-binding polymers for oral administration |
11 Aug, 2013
(11 years ago)
| Expired |
| US6858203 | Method of making phosphate-binding polymers for oral administration |
11 Aug, 2013
(11 years ago)
| Expired |
| US7014846 | Phosphate-binding polymers for oral administration |
11 Aug, 2013
(11 years ago)
| Expired |
| US7459151 | Phosphate-binding polymers for oral administration |
11 Aug, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Renvela's drug page